Φορτώνει......
Phase I Study of Erlotinib Plus Radiation Therapy in Patients with Advanced Cutaneous Squamous Cell Carcinoma
PURPOSE: Recurrent or advanced stage cutaneous squamous cell carcinoma (cSCC) is difficult to treat and available therapies have a high failure rate. Anti-epidermal growth factor receptor therapy (EGFR) is associated with a facial rash that may potentiate radiation related cutaneous toxicities. The...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2012
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607201/ https://ncbi.nlm.nih.gov/pubmed/23182701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.09.030 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|